SS25 3-10 Inhaled Anesthetics Part 2 (Exam 3) Flashcards

1
Q

What are the purposes of the anesthesia circuit?

A
  • Delivers O₂ and inhaled anesthetics
  • Maintenance of temperature & humidity
  • Removal of CO₂ and exhaled drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how the anesthesia circuit maintains temperature/ humidity.

A

Utilizes the nose/pharnyx to maintain natural moisture and warmth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What types of gas delivery systems are there?

A
  • Rebreathing (Bain system)
  • Non-rebreathing (self-inflating BVM system)
  • Circle systems (Anesthesia machine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • Why is the BVM system a great way to give volatile anesthetics?
  • What is the key difference with the BVM reservoir bag?
  • What can you add to BVM system?
A

**- Trick question! ** Non-rebreathing BVM system is not a good way for inhaled drugs. It’s very effective for O2 and air delivery.
- Must self-inflate
- Able to build on it: add peep; add another bag; add O2

Side note:The way the BVM is set up can control how much re-breathing we have

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of system is depicted below?
Where is the aPL valve located on this system?

A
  • Bain Circuit = Rebreathing
  • Blue circle depicts aPL below.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List key characterictics of Bain circuit based on labeled points

A
  • A: Patient end that connects to ETT
  • B: Able to connect to supplemental O2 via side port
  • C: Another O2 connector option
  • D: Acts as typical reservior bag
  • E: APL valve open/ shut to make bag inflate more or less (control positive pressure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In the figure below, what portion of the anesthesia circle system is indicated by 1?

A

Inspiratory Unidirectional Valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In the figure below, what portion of the anesthesia circle system is indicated by pink arrow?

A

Fresh Gas Inlet (O₂ & medical air)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In the figure below, what portion of the anesthesia circle system is indicated by 2?

A

CO₂ Absorber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In the figure below, what portion of the anesthesia circle system is indicated by 3?

A

Bag/Ventilator Selector Switch

Bag inspiratory drive v. vent inspiratory drive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In the figure below, what portion of the anesthesia circle system is indicated by 4?

A

APL Valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In the figure below, what portion of the anesthesia circle system is indicated by 5?

A

Expiratory Unidirectional Valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the figure below, what portion of the anesthesia circle system is indicated by 6?

A

Expiratory Limb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In the figure below, what portion of the anesthesia circle system is indicated by 7?

A

Y-Piece
- ETT connection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When fresh gas flow (FGF) exceeds V̇m then you have _________________.

A

High Flow Anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When V̇m exceeds fresh gas flow (FGF) then you have _________________.

A

Low Flow Anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When would one see rapid changes in anesthetic, lack of rebreathing, wasteful volatile use, and cool dried air?

A

High Flow anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are common indications for high flow delivery?

A
  • Build up O2 reserve (Pre-oxygenate)
  • Rid N2 (Denitrogenate)
  • Esp. in elderly and comorbid populations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

For high flow anesthesia, you want to ____ (increase/decrease) gas concentration and ____ (increase/decrease) flow rate.

A
  • increase; increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When would one see lower cost d/t less volatile use, less cooling/drying of air, and slow changes in anesthetic?

A

Low Flow anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is Compound A?

A
  • Metabolite produced during Low Flow Sevo anesthesia and CO2 absorbent
  • Low flow anesthesia (LFA) is 2 L/min (lower than normal Vm)
  • Nephrotoxin
  • No longer a concern but was prevalent for decades so will still be in literature/ discussed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the CO2 absorbent made of?
- How is this rlt Compound A?
- What was the rat discovery?

A
  • CO2 absorbent is made of Potassium (K+) and Sodium Hydroxide (NaOH)
  • Increase CO2 absorbant eith low flow sevo created Compound A (nephrotoxin)
  • Discovered it takes about 100 parts per million (ppm) to cause Acute tubular necrosis (ATN) in rats and 400 ppm to kill them
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Scientific word for Compound A:

A
  • Fluoromethyl-2,2-difluro-1-vinyl ether
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What do we know about Compound A now in modern day?

A
  • 75% or more is now made out of Ca(OH)₂
  • No clinical date to support Compound A is a risk at LFA
  • Breathing circuit trial: @ flows of 1, 3 , 6 L/min we had 19.7, 8.1, 2.1 ppm
  • Showed no change in BUN/ creat, no proteinuria & no glucosuria
  • D/t low ppm not clincally significant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the quickest way to get a patient to stop responding to surgical stimuli?

A
  • Turn up gas concentration and flow rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Do volatiles cause bronchostriction or bronchodilation?

A

Bronchodilaton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How do volatiles cause bronchodilation?

A
  • Blockage of VG Ca⁺⁺ channels
  • Depletion of SR Ca⁺⁺
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Is the bronchodilatory effect of volatiles still present in someone with reactive airway disease?

A
  • No (or very little effect). Bronchodilatory effects of volatiles require an intact epithelium
  • inflammatory processes & epithelialdamage alters effectiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Will volatiles cause bronchospasm on their own (in a patient with no history of bronchospasm)?

A

No

Histamine release or vagal afferent stimulation needed to cause spasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

In a patient without history of bronchospasm, how much would you anticipate PVR to change with 1-2 MAC?

A

PVR would be unchanged in patient with no history of bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What risk factors increase risk of bronchospasm?

A
  • Coughing w/ ETT in place
  • <10 years old
  • URI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What anesthetic is generally the best at bronchodilating?

A
  • Sevoflurane (1st)
  • Isoflurane (2nd)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Inhaled anesthetic of choice for pediatric patients:

A
  • Sevoflurane

Sevo! Sevo! Sevo!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Which anesthetic can function as a pulmonary irritant?
- This leads to?
- Which population is at an increased risk?

A
  • Desflurane
  • Worsening bronchospam
  • Smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Which volatile anesthetic in the graph below caused the greatest increase in airway resistance?
Lowest?

A
  • Desflurane = ↑ airway resistance
  • Sevoflurane = ↓ airway resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

T/F: Inhaled anesthetics have a dose-dependent skeletal muscle contraction mediated via spinal cord.

A
  • False
  • dose dependent skeletal muscle Relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Which volatile gas has no effect on the relaxation of skeletal muscles?

A
  • N₂O (Nitrous Oxide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Will volatiles potentiate or inhibit depolarizind and non-depolarizing NMBD’s?
- If so, how?

A
  • **Potentiates **
  • via sensitization of nACh receptors at NMJ
  • via enhancement of glycine at the spinal cord

Side note: Volatile anesthetics cause enhancement of glycine leading to skeletal muscle relaxation as a solo agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is ischemic preconditioning?

A

Brief periods of ischemia preparing the heart for longer periods of ischemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Ischemic preconditioning with volatile anesthetics can occur as low as what MAC level?

A

0.25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What molecule mediates ischemic preconditioning?

A

Adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Why does ischemic preconditioning happen?
(IPRV)

A
  • Increases PKC activity
  • Phosphorylation of ATP sensitive K⁺ channels
  • Production of ROS
  • Better vascular tone regulation

PKC = Protein Kinase C
ROS = Reactive Oxygen Species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What does ischemic preconditioning prevent?

A
  • Reperfusion injuries
  • Cardiac dysrhythmias
  • Contractile dysfunction
  • Delays MIs for PTCA and CABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

At what dose does volatile depression of CMRO₂ and cerebral activity begin?

A
  • 0.4 MAC as wakefulness changes to unconsciosness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

At what MAC would we see EEG burst suppression?
What about total electrical silence?

A
  • 1.5 MAC = burst suppression
  • 2 MAC = EEG electrical silence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

At what MAC does 50% of patients not move to supermaximal stimuli (ie: surgical cut)?

A
  • 1.0 MAC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which volatile causes the most EEG suppression?

A
  • Trick question. They all affect EEG’s the same.
  • ’‘SID’’

Isoflurane = sevoflurane = desflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Which volatiles have anticonvulsant activity?
- At high or low concetrations?
- With hypercarbia or hypocarbia?

A
  • DIS: Des, Iso, &Sevo
  • At high concentrations & with hypocarbia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Which volatile is a proconvulsant?
- Risk factors?

A
  • Enflurane
  • Especially above 2.0 MAC or PaCO2 < 30 mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Give an example of a somato-sensory evoked potential (SSEP).

A

Stimulation of the foot evoking an electrical response in the CNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Give an example of a motor-evoke potential (MEP).

A

Direct stimulation of the brain eliciting a twitch response in the hand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

You have a case where SSEPs and MEPs need to be monitored, what general anesthetics options do you have?

A
  • TIVA
  • N₂O 60% and 0.5 MAC volatile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What specific effects will volatile agents have on SSEPs and MEPs?

A

Dose-dependent (0.5 - 1.5 MAC):

  • ↓ amplitude
  • ↑ latency (delayed frequency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What effects does volatiles have on cerebral blood flow (CBF)?

A
  • Dose-dependent effects
  • ↑ volatile adminstration = ↑ vasodilation = ↑ CBF
  • Can lead to ↑ ICP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

At what MAC onset do you start to see an ↑CBF due to volatile administration?

A
  • Onset > 0.6 MAC

Occurs within minutes despite lack of BP change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Which volatile has less vasodilatory effects?

A

Sevoflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Which volatile has the greatest effect on increasing CBF/ICP?

A

Halothane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Which volatile is the best for neuro cases? Why?

A
  • Sevoflurane
  • Preserves autoregulation mechanism up to 1 MAC

Hesd injuries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Is Sevo isn’t available what is the next option for volatile use with CBF management?

A
  • Iso and Des pretty much equal effects per Dr. Kane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What patient population is most at risk due to the ICP increasing effects of volatile agents?

A

Patients with space-occupying lesions

61
Q

At what volatile dosage does ICP increase?
- How much of an increase do we typically see?

A
  • Onset > 0.8 MAC
  • Increase in ICP by 7 mmHg
62
Q

What opposes increased ICP?

A
  • Hyperventilation
63
Q

T/F: Nitrous is a potent vasodilator

A
  • True
  • Avoid diffusion into airspaces (ie: pneumocephalus)
64
Q

Explain autoregulation differences between Halo, Sevo, Iso, & Des.

A
  • Sevo preserves to 1 MAC
  • Halo lost by 0.5 MAC
  • Iso & Des lost by 0.5 - 1.5 MAC

Autoregulation varies patient to patient

65
Q

Based off image, explain autoregulation.

A
  • ICP, MAP, PaCO2, & PaO2 autoregulated between 50 - 150 mmHg
  • Our goal is tomaintain within autoregulation (MAP > 60 mmHg / within 20% of baseline)
  • Volatiles can cause expected shifts outside of autoregulation; must be prepared to treat those
66
Q

What do volatiles do to the respiratory system?

A

Dose-dependent:

  • Respiratory depression
  • ↑ rate (Tachypnea)
  • ↓ VT
  • The more volatile used, the faster & shallower the patient will breath

The more volatile used, the faster&shallower thr patient will breath

67
Q

How do volatiles cause their respiratory depression?

A
  • Direct depression of medullary ventilatory center
  • Interference with intercostal muscles
  • Rate change insufficent to miantin Vm or PaCO2
68
Q

Describe physical change in breathing muscles during respirstory depression.

A
  • Diaphragm descends and chest wall collapses inward
69
Q

At what volatile dosage would apnea be seen?

A

1.5 - 2.0 MAC

70
Q

T/F: All volatiles will blunt both the hypoxic and hypercarbic response

A
  • False. N₂O does not blunt the hypercarbic response
  • N₂O does not increase PaCO2

All volatiles blunt hypoxic response (including N2O)

71
Q

How can the hypercarbic response be preserved while using volatile anesthetic gasses?

A
  • Use N₂O and volatile together (less depression)
72
Q

What usually mediates blunting of hypoxic response with volatile administration?
- At what MAC(s)?

A
  • Mediated by Carotid bodies
    - 0.1 MAC= 50 - 70% depression
  • 1.1 MAC = 100% depression
73
Q

Based on image, explain CO2 response to volatile use.

A
  • All volatiles have a significant increase in PaCO2 (except N2O)
  • Use of N₂O-desflurane decreases CO2-induced hypercarbia compared to desflurane alone.
74
Q

What is hypoxic pulmonary vasoconstriction (HPV)?

A
  • Compesatory contraction of pulmonary artery smooth muscle to shunt blood away from poorly ventilated portions of the lung.
  • Optimizes VQ
75
Q

When is HPV most concerning?

A
  • In One-lung ventilation
76
Q

How fast is the HPV response?

A
  • Fast: within 5 minutes regional blood flow is ½ of normal
  • Max response lasts up to 2 - 4 hours
77
Q

50% depression of HPV occurs at ___ MAC.

A
  • 2 MAC
  • Volatiles cause a dose-dependent decrease HPV response but we never give 2 MAC for an entire case so we shouldn’t see this ever
78
Q

Which volatile(s) does not cause cardiac depression?

A
  • N₂O (Nitrous)
79
Q

How do volatiles effect MAP?
- What dose-dependent changes occur?

A
  • Direct myocardial depression by altering Ca⁺⁺ entry and SR function
  • Dose-dependent ↓ in contractility, SVR, CO, & MAP

Most decrease seen with Halothane use “ H for heart probs”

80
Q

When is volatile depression of cardiac function most concerning?

A
  • In diseased hearts with altered contractility
81
Q

What effect does volatiles have on heart rate?

A
  • Dose-dependent increases in HR
82
Q

What volatile can cause significant tachycardia with overpressurization?

A
  • Desflurane
  • Iso and Des can cause increased tachycardia at lower MAC concentrations than Sevo
83
Q

When will sevoflurane begin to cause increases in heart rate?

A
  • Only when > 1.5 MAC
84
Q

What variables cofound/ obscure the tachycardic effect of volatiles?

A
  • Anxiety
  • Concurrent opioids
  • β blockade
  • Vagolytics
85
Q

Compare CI/CO effects of volatile usage.

A
  • Dose- dependent decrease in CI/CO
  • Halothane has most decrease in CO
  • Isoflurane seems to maintain CO up to about 1 MAC
86
Q

What volatile is sympathomimetic, causing a slight increase in CO?

87
Q

What’s coronary steal syndrome?
- Is it clinically significant?

A
  • Volatiles induce coronary vasodilation on 20-50 mm vessels preferentially
  • Redistribution of blood from ischemic to non-ischemic regions
  • Not significant
88
Q

What electrocardiac effect do volatiles have?
- This causes an increase risk of what arrythmia?

A
  • QT prolongation via inhibition of K⁺ currents in healthy patients
  • Torsades

Be aware of other meds being used that proolong QT as well (ie: Zofran)

89
Q

Which volatile has minimal pro-arrhythmic activity?

90
Q

Which volatile is the choice for EP ablations and why?

  • Which volatile is poor choice for EP studies and why?
A
  • Sevoflurane; no negative effects with ablations
  • Isoflurane increases refractoriness of accessory pathways making identification of arryhthmia location difficult.
91
Q

Volatile neuroendocrine stress response: will cause a perioperative surge in

A
  • ANS and HPA (Hypothalamus Pituitary Axis) activated
  • Perioperative surge in catecholamines, ACTH, & cortisol

“We know a lot about volatiles thanks to Edmond Eger” - Dr. Kane

92
Q

Volatiles suppress what important immune system components?

A
  • Volatiles suppress Monocytes, Macrophages, and T-cells (MMT)
93
Q

What does the total neuroendocrine profile of volatile anesthetics suggest for cancer patients undergoing surgery?

A
  • Neuraxial anesthesia is likely better than GA for cancer patients
  • Evidence shows GA increases metastasis and mortality
  • TIVA may be better choice for Ca patients
94
Q

What hepatic blood flow changes are seen with volatile administration?

A
  • Total hepatic BF maintained
  • Hepatic artery flow maintained
  • Portal vein flow increased d/t vasodilation
95
Q

What MAC dose does portal vein flow increase?

A
  • 1 - 1.5 MAC
96
Q

Which volatile(s) decrease portal vein flow?

A
  • Halothane
  • Halothane Hepatitis common
  • Decreases O2 delivery
97
Q

What is volatile hepatotoxicity?
-When is it a concern?

A
  • Inadequate oxygenation of hepatocytes via ↓ blood flow, enzyme induction and ↑ O₂ demand
  • Concern for patients with preexisting liver disease
98
Q

What is Type 1 Volatile hepatotoxicity?

A
  • Direct toxic or free radical effect 1-2 weeks post surgically
  • Flu-like symptoms (N/V, lethargy, & fever)
    -20% of patients; more common than Type 2
99
Q

What is Type 2 Volatile Toxicity?

A
  • Immune-mediated (IgA) response against hepatocytes caused by previous exposure to volatile
  • Charecterized by eosinophilia & fever
  • Occurs 1 month after exposure
  • Higher mortality with Acute hepatitis and necrosis

Why we don’t use Halothane in US

100
Q

Volatile of choice for severe liver disease?
- Why?

A

-Sevoflurane: Metabolized to vinyl halide
- Unable to stimulate antibody production causing a Type II reaction

101
Q

What volatiles are metabolized into acetyl halides?
- What is the significance of this?

A
  • Enflurane > Iso > Des
  • Oxidixed by P450 to acetyl halides
  • Acetyl halides can cause antibody reactions especially with previous exposure to Halothane or Enflurane
102
Q

What are the renal effects of volatile anesthetics?

A
  • Dose dependent decrease in RBF, GFR, and UO from CO depression
  • Foleys for surgeries > 2 hrs
  • Expect lower UOP d/t volatiles and may be positioning (gravity) (not rlt to Vasopressin release)
103
Q

How can the renal effects of volatile anesthetics be counteracted?

A
  • Pre-Op Hydration
104
Q

What other organ (besides the heart) undergoes protective ischemic preconditioning from volatile anesthetics?

105
Q

What toxic metabolites of volatiles can cause nephrotoxicity?
- Nephrotoxic presentation?
- Why is this not an issue typically?

A
  • Fluoride metabolites
  • Hyperosmolarity, HyperNa, Increased creatinine (HIH)
  • Newer volatiles have lower solubility so they’re **exhaled prior to being metabolized **
106
Q

What volatile is 70% metabolized and can cause fluoride metabolite nephrotoxicity more than any of the other volatiles?

A

Methoxyflurane

Removed from market

107
Q

What measure is utilized in CO₂ absorbents today to help prevent the formation of compound A?

A
  • 75% or greater concentrations of calcium hydroxide [Ca(OH)₂]
108
Q

What volatile is predisposed to starting fires? Why?

A
  • Sevoflurane
  • Sevo + desiccated absorbent produces methanol and formaldehyde causing a heat and speeding up reactiom which can lead to spontaneous combustion
109
Q

How is sevoflurane fire avoided?

A
  • Add water to Sevo
  • Check temp of absorbent cannister (should feel like room temp; shouldn’t be hot)
110
Q

Malignant Hyperthermia:
- Causes
- MOA
- S&S
- Diagnostic test
- Treatment

A
  • Caused by all inhaled Volatiles and Succs
  • MOA: Hypermetabolic state of skeletal muscle: Excessive Ca release; muscle rigidity; Rhabdo
  • S&S: Fever, hypercarbia, hypoxia
  • Test: Caffeine contracture test
  • Tx: Dantrolene

80% mortality (high)

111
Q

MOA of Dantrolene:

A
  • Ca-channel blocker
  • Blocks intracellular Ca release
  • Supportive care for Rhabdo
112
Q

Which volatile anesthetics are emetogenic?

A
  • All

Maybe just TIVA; no volatiles

113
Q

What rate of PONV is seen with two triggering agents?
- Example of triggering agents?

A
  • 25 - 30% PONV
  • Volatile + Opioid
  • Other risk factors: - Females, abd sx, pregos, red heads

Pre-op combo drugs

114
Q

When is N₂O pro-emetic?

A
  • Greater than 0.5 MAC
  • Just don’t give it
115
Q

Metabolic effects of volatiles:
(BMH)

A
  • B12 deficiency
  • Megaloblastic BM supression
  • High plasma homocysteine levels
116
Q

Why is N₂O administration in a pregnant patient with B12 deficiency dangerous?

A
  • N₂O will oxidize the cobalt ion in B12 thus inhibiting methionine synthase = inhibition of DNA synthesis in fetus
  • High risk: 1st tri pregos
117
Q

Which volatile anesthetic can cause megaloblastic bone marrow suppression?

A
  • N₂O
  • After 24 hrs after exposure; repeated exposured < 3 days cumulative intervals
  • high risk: Immunocompromised patients
118
Q

What is the result from increases in plasma homocysteine levels from N₂O administration?

A
  • If the patient also has low B vitamins and atherosclerosis, then N₂O increases risk of myocardial events
119
Q

OB effects of volatile use:

A
  • Dose-dependent (0.5 - 1.0 MAC) decrease in uterine smooth muscle contractility
120
Q

When would a decrease in uterine muscle tone be useful?

A
  • With retained placenta
  • Increase volatile to dilate
121
Q

When would an increase in uterine muscle tone be useful?

A
  • Uterine atony (↑ blood loss)
  • Decrease volatile
122
Q

Why is N₂O useful in mom’s post delivery?

A
  • Swiftly increases analgesia without opioid/benzos (use as the spinal starts to wear off)
  • No effect on contractility
123
Q

Which volatiles have a sweeter smell (non-pungent)?

A
  • Halothane
  • Sevoflurane
124
Q

Halothane profile:
- molecular makeup?
- high or low potency?
- sweet or smelly odor?
- high, intermediate, or low solubility?

A
  • Halogenated alkane
  • Compatible with inhalation induction: high potency; sweet/ non-pungent odor
  • Intermediate solubilty = wants to stay in blood (so slower induction and a slower wake up)
125
Q

Benefit(s) of Halothane:

A
  • Lower risk of N/V
  • Non-flammable
126
Q

What are the four major concerns of Halothane?
(CHPD)

A
  • Catecholamine-induced arrhythmias
  • Hepatic necrosis
  • Pediatric brady-arrhythmias
  • Decomposing into HCL acid (Thymol preservative added)
127
Q

Which two volatiles can’t be used for induction due to their awful smell/pungent?

A
  • Isoflurane
  • Desflurane
128
Q

Which volatile does not degrade, even after 5 years of storage?

A

Isoflurane

129
Q

Isomer of Enflurane:

A
  • Isoflurane (Forane)

Creation order: Halothane → Enflurane → Isoflurane

130
Q

Which volatile is considered most famous/popular per lecture?

A
  • Desflurane (Suprane)

Sevo also very popular

131
Q

Isoflurane profile:
- high or low potency?
- sweet or smelly odor?
- high, intermediate, or low solubility?
- name of purification process?
- Is it nephro/hepatotoxic?
- Shelf life?

A
  • Highly potent
  • Highly pungent
  • Intermediate solubiity
  • $$$ to purify (Distillation)
  • No, Resistant to metabolism (avoids toxicity)
  • Stable; no deterioration after 5 years
132
Q

Which inhaled volatile requires a vaporizer with a heating element?

A
  • Desflurane
  • Requires special vaporizer
133
Q

Desflurane profile:
- molecular make up?
- what volatile is it very similar to?
- what is the difference b/w them?

A
  • Fluorinated methyl ethyl ether
  • Identical to Isoflurane except Fluoride substituted for Chloride
134
Q

Desflurane profile:
- high, intermediate, or low potency?
- sweet or smelly odor?
- high or low vapor pressure?

A
  • low potency
  • low solubility (wants to leave blood and go to receptors)
  • Most pungent (coughing, salivation, breath holding, laryngospasm occurs in greater than 6%)
135
Q

What happens if you over-pressurize Desflurane?
- Mediated by what?

A
  • Tachycardia d/t SNS stimulation
136
Q

What does Des degrade into?
- Cause?
- How could this happen?

A
  • Will degrade into Carbon monoxide (CO) if absorbent dehydrates
  • Could happen if you forget to turn O2 flow meter off
137
Q

List the order in which volatiles will degrade into carbon monoxide if the absorbent becomes exhausted.

A
  • Desflurane (worst) > Enflurane
    > Isoflurane > Sevoflurane (trivial)

DEIS

138
Q

Which volatile anesthetic would be the choice for inhalation induction? Why?

A
  • Sevoflurane
  • Smells sweet = Least airway irritation of modern volatiles
139
Q

Sevo profile:
- molecular make up?
- high, intermediate, or low potency?

A
  • Fluorinated methyl isopropyl ether
  • low solubility
140
Q

Neuro effects of Sevo:
- How does it effect ICP?
- How does it effect lidocaine-induced seizures?

A
  • Least cerebral vasodilation
  • Drug of choice (DOC) for increased ICP
  • Supresses lidocaine-induced sz activity
141
Q

Pop Quiz: What’s the blood:gas coefficient for Sevo and Des?
- Which one has the lower/poorer solubility? Clinical significance?

A
  • Sevo = 0.69
  • Des = 0.42 (lower solubility)
  • The lower the solubilty the more it wants to leave blood and go to receptors in brain (VRG), fat, etc.
142
Q

Sevo metabolism:
- Metabolite?
- Does is for CO and Compound A?

A
  • Inorganic Fluoride
  • All volatiles can form CO but Sevo is least likely
  • We now know it won’t form toxic levels of Compound A from Low Flow

Sevo = super safe and predominant volatile

143
Q

Nitrous Oxide (N₂O) profile:
- high or low potency?
- sweet or smelly odor?
- high, intermediate, or low solubility?

A
  • Low potency
  • Sweet/odorless
  • Lowest solubility
144
Q

How does N₂O produce skeletal muscle relaxation?

A
  • Trick question! It does not.
  • Unable to be sole anesthetic b/c can’t deliver1 MAC
145
Q

What are the benefits of N₂O ?

A
  • Good analgesic properties (ie: spinal wearing off, dentist fillings)
  • 2nd gas effect
146
Q

What’s 2nd gas effect?

A
  • Quicker inhalation b/c N₂O diffuses in then out of pulmonary capillaries and they collapse causing the concentration
147
Q

What are negatives of N₂O ?

A
  • N/V > 50% @ 0.5 MAC
  • ↑ PVR
  • No surgeries with air filled spaces
148
Q
  • N₂O is contraindicated in what patient population? Why?
A
  • Neonates
  • May increase right-to-left shunt
  • Jeopardizes arterial oxygenation